EPIC Epinephrine Patent Lawsuit Against BPI Labs Moves Forward

Belcher Pharmaceuticals LLC must face Endo Par Innovation Co. LLC’s lawsuit accusing it of copying a patent-protected formula for stable injectable epinephrine, a life-saving medication for people suffering severe allergic reactions.

Judge William F. Jung of the US District Court for the Middle District of Florida denied Belcher and BPI Labs LLC’s motion to dismiss the lawsuit in a Thursday opinion.

Endo Par—better known as EPIC—won US regulatory approval for a reformulated Adrenalin, an injectable version of epinephrine, in 2015 and 2016, according to Jung’s opinion. The Food and Drug Administration had expressed concerns about the epinephrine formulation in ...